New treatment for dizziness in people with multiple sclerosis
Official title: Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Run by Emory University · NCT06495138 · Data updated 2026-11-12
This study tests a new treatment using a special technology to see if personalized eye exercises can help reduce dizziness for people with multiple sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 89 Years |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | Emory University Academic / other |
| Drugs / interventions | Immunotherapy |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | April 21, 2025 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT06495138 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a confirmed diagnosis of primary progressive or relapsing-remitting MS who experience dizziness and have a history of falls.
✕Probably not a fit
Patients with clinically isolated syndrome, significant cognitive impairment, or certain ocular conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a novel treatment aimed at alleviating dizziness in individuals with multiple sclerosis (MS). It compares daily personalized gaze stabilization training to intermittent gaze stability training to determine which is more effective. The intervention utilizes a technology called StableEyes, designed to enhance gaze stability through a gradual approach to vestibular exercises. By targeting the vestibulo-ocular reflex, the study aims to improve vision stability and reduce dizziness, ultimately enhancing the quality of life for participants.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce dizziness and improve daily functioning for patients with multiple sclerosis.
How similar studies have gone: Preliminary research has shown promising results for similar approaches, suggesting potential effectiveness for this novel treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MS per The 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging in MS, or a healthy volunteer without a diagnosis of multiple sclerosis or any related neurological conditions * Fluent in speaking and understanding English * Subjects with multiple sclerosis have self-reported vestibular symptoms of dizziness, imbalance, and/or a history of at least two falls in the prior 12 months Exclusion Criteria: * Clinically isolated syndrome or radiologically isolated syndrome. * Worsening MS symptoms during the prior 60 days * Immunotherapy change in the prior 60 days * Self-reported cognitive impairment that limits independence with basic and instrumental activities of daily living * Systolic blood pressure \> 180 mmHg and/or diastolic blood pressure \> 90 mmHg at rest * Static visual acuity with correction of worse than 1.0 logMAR * Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus} * Convergence insufficiency * Intra-nuclear ophthalmoplegia * Vestibular Migraine * Major orthopedic conditions that limit cervical spine range of motion or that alter walking * Self-reported current or potential for pregnancy during enrollment * Ongoing participation in vestibular rehabilitation for dizziness
Where it's running
-
Emory Univeristy
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Colin Grove, PT, MS, DPT, PhD — Emory University
- Study coordinator: Colin Grove, PT, DPT, MS, PhD
- Email: colin.r.grove@emory.edu
- Phone: (404) 712-8685
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.